Mind-body Medicine for Adolescents and Young Adults (AYA) Coping with Hodgkin Lymphoma
Dr. Milbury will conduct a pilot randomized controlled trial to test the feasibility and initial efficacy of a mind-body intervention targeting the psychosocial needs of adolescents and young adults (AYAs; ages 15-39) with Hodgkin Lymphoma. AYAs with a new Hodgkin Lymphoma diagnosis will complete baseline measures of psychological distress and cancer symptoms and blood draws for biomarker analyses. Then, they will be randomized to the intervention or an attention control group. Both study arms will be delivered in a group setting (5 sessions total; 75 min each) via videoconference. All participants will be reassessed 6 and 12-weeks later.